Neurocrine Biosciences Announces Webcast and Conference Call To Present Second Quarter 2002 Results and Company Update
SAN DIEGO, July 29 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report second quarter financial results on Tuesday, July 30, 2002. Neurocrine will also host a Conference Call and Webcast to discuss its financial results and provide a company update on Wednesday, July 31, 2002 at 9:00AM Eastern Daylight Time (EDT)/6:00AM Pacific Daylight Time (PDT). Participants may access the live Conference Call by dialing 1-800-233-2795 (US) or 785-832-1077 (International). The call can also be accessed via the Webcast through the Company's website at www.neurocrine.com or through a link provided by PRNewswire at http://www.firstcallevents.com/service/ajwz363474019gf12.html .
Gary A. Lyons, President and CEO of Neurocrine Biosciences and Paul W. Hawran, Executive Vice President and CFO will be presenting the financial results for second quarter 2002 as well as give a Company update. If you are unable to attend the Webcast and would like further information on this announcement please contact Claudia Jones or Elizabeth Foster in the Investor Relations Department at Neurocrine Biosciences at (858) 658-7600.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, malignant brain tumors and peripheral cancers, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, stroke, and certain female health disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com .
MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X70121536
SOURCE Neurocrine Biosciences, Inc.
Web site: http: //www.neurocrine.com
CONTACT: Claudia Jones or Elizabeth Foster, both of Neurocrine Biosciences, Inc., +1-858-658-7600
Audio: http: //www.firstcallevents.com/service/ajwz363474019gf12.html